Search

Subject 616.992

7711. Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer. (13th August 2019)

Authors:
Hortobagyi, G N; Stemmer, S M; Burris, H A; Yap, Y S; Sonke, G S; Paluch-Shimon, S; Campone, M; Petrakova, K; Blackwell, K L; Winer, E P; Janni, W; Verma, S; Conte, P; Arteaga, C L; Cameron, D A; Mondal, S; Su, F; Miller, M; Elmeliegy, M; Germa, C
Journal:
Annals of oncology
Issue:
Volume 30:Number 11(2019)
Page Start:
1842
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7712. Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer. (27th April 2018)

Authors:
Hortobagyi, G N; Stemmer, S M; Burris, H A; Yap, Y S; Sonke, G S; Paluch-Shimon, S; Campone, M; Petrakova, K; Blackwell, K L; Winer, E P; Janni, W; Verma, S; Conte, P; Arteaga, C L; Cameron, D A; Mondal, S; Su, F; Miller, M; Elmeliegy, M; Germa, C
Journal:
Annals of oncology
Issue:
Volume 29:Number 7(2018)
Page Start:
1541
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7713. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. (3rd July 2018)

Authors:
Gehl, Julie; Sersa, Gregor; Matthiessen, Louise Wichmann; Muir, Tobian; Soden, Declan; Occhini, Antonio; Quaglino, Pietro; Curatolo, Pietro; Campana, Luca G.; Kunte, Christian; Clover, A. James P.; Bertino, Giulia; Farricha, Victor; Odili, Joy; Dahlstrom, Karin; Benazzo, Marco; Mir, Lluis M.
Journal:
Acta oncologica
Issue:
Volume 57:Number 7(2018)
Page Start:
874
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7715. Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial. (18th January 2019)

Authors:
Herbst, R S; Baas, P; Perez-Gracia, J L; Felip, E; Kim, D -W; Han, J -Y; Molina, J R; Kim, J -H; Dubos Arvis, C; Ahn, M -J; Majem, M; Fidler, M J; Surmont, V; de Castro, G; Garrido, M; Shentu, Y; Emancipator, K; Samkari, A; Jensen, E H; Lubiniecki, G M
Journal:
Annals of oncology
Issue:
Volume 30:Number 2(2019)
Page Start:
281
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗